Kamada (KMDA) Current Assets (2012 - 2026)
Kamada's (KMDA) quarterly Current Assets came in at $199.2 million in Q1 2026, up 5.69% YoY from $188.5 million in Q1 2025, and up 3.19% on a QoQ basis from $193.1 million in Q4 2025.
Kamada (KMDA) Current Assets (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 13 years of Current Assets data on file, last reported at $199.2 million in Q1 2026.
- Quarterly Current Assets rose 5.69% year-over-year to $199.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.2 million (up 5.69% YoY) and the FY2025 annual result came in at $193.1 million, up 4.73% from the prior year.
- Current Assets grew to $199.2 million in Q1 2026, from $193.1 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $199.2 million in Q1 2026 to a low of $131403.0 in Q1 2023.
- A 5-year average of $144.5 million and a median of $164.4 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets plunged 99.92% — and 2024, when it surged 119994.67%.
- Tracing KMDA's Current Assets over 5 years: stood at $139.0 million in 2022, then grew by 22.27% to $170.0 million in 2023, then rose by 8.46% to $184.3 million in 2024, then grew by 4.73% to $193.1 million in 2025, then gained by 3.19% to $199.2 million in 2026.
- The last three Current Assets figures came in at $199.2 million (Q1 2026), $193.1 million (Q4 2025), and $192.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 3.22 Bn |
| 10 | Kamada | 458.29 Mn | 428.82 Mn | 22.47 Mn | 199.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 199.57 Mn |
| Mar 31, 2026 | 199.24 Mn |
| Dec 31, 2025 | 193.08 Mn |
| Sep 30, 2025 | 192.73 Mn |
| Jun 30, 2025 | 183.27 Mn |
| Mar 31, 2025 | 188.50 Mn |
| Dec 31, 2024 | 184.35 Mn |
| Sep 30, 2024 | 164.41 Mn |
| Jun 30, 2024 | 166.43 Mn |
| Mar 31, 2024 | 157.81 Mn |
| Dec 31, 2023 | 169.96 Mn |
| Sep 30, 2023 | 153.15 Mn |
| Jun 30, 2023 | 129.68 Mn |
| Mar 31, 2023 | 131,403.00 |
| Dec 31, 2022 | 139.01 Mn |
| Sep 30, 2022 | 135,162.00 |
| Jun 30, 2022 | 118.60 Mn |
| Mar 31, 2022 | 116.16 Mn |
| Dec 31, 2021 | 130.04 Mn |
| Sep 30, 2021 | 178.94 Mn |